Elixi, Author at Elixi International - Page 8 of 13

11 May 2020

Novartis announces FDA approval of MET inhibitor Tabrecta (capmatinib)for metastatic non-small cell lung cancer with METex14

0 Comments4 Minutes

27 April 2020

MenQuadfi is Sanofi’s Latest vaccine for the prevention of invasive meningococcal disease (MenACWY)

0 Comments4 Minutes

18 April 2020

Tukysa (tucatinib) new option of treatment of adult patients with advanced forms of HER2-positive breast cancer

0 Comments5 Minutes

13 April 2020

Koselugo (selumetinib), newly approved treatment of neurofibromatosis type 1 (NF1)

0 Comments5 Minutes

3 March 2020

Sarclisa (isatuximab-irfc), new Therapy for Patients with Previously Treated Multiple Myeloma

0 Comments4 Minutes

28 February 2020

Ofatumumab, the new potential first-choice treatment for Relapsing forms of Multiple Sclerosis

0 Comments2 Minutes

22 February 2020

FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome

0 Comments4 Minutes

11 February 2020

FDA Grants Priority Review for Kite’s KTE-X19 Biologics License Application (BLA) in Relapsed or Refractory Mantle Cell Lymphoma

0 Comments2 Minutes

9 February 2020

First Cardiac Ultrasound Software That Uses Artificial Intelligence to Guide User

0 Comments5 Minutes

5 February 2020

Givlaari (givosiran), first treatment for acute hepatic porphyria

0 Comments3 Minutes